Epogen counterfeit product alert

Amgen, with the knowledge of FDA, notified pharmacists and health care providers of counterfeit EPOGEN (epoetin alfa). EPOGEN 40,000 U/mL vials in ten-pack boxes, lot number P002970 expiration date: 7/03 has been found to contain active ingredient that is approximately 20 times lower than would be expected for EPOGEN in 40,000 U/mL vials. Pharmacists and health care providers should carefully examine all vials of EPOGEN before use. A brief description and pictures of the differences between the actual product and the counterfeit are provided.
Read the MedWatch 2002 Safety Summary, including photos and a link to the “Dear Healthcare Professonal” letter, at:
http://www.fda.gov/medwatch/SAFETY/2002/safety02.htm#epogen
http://wwwext.amgen.com/news/news02/release020506.html